Delivery Order SPE2DB24D3015-SPE2DB24FFXQY

Award Date 9/5/24
Potential Completion Date 9/6/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $16,546.86 firm-fixed-price contract has a completion date of November 5, 2024, and was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,726.46 and an ultimate completion date of May 23, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA). The $13,503.98 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 21, 2024. The contract has an ultimate completion date of August 22, 2024 and does not utilize any set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,174.46, is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of November 13, 2023 and was awarded on November 9, 2023. This contract is part of a larger Indefinite Delivery Contract (IDC) held by...
The federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS medical products. The contract, valued at $9,555.20, is a Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of December 3, 2024. The contract is a Firm Fixed Price arrangement and is not designated with any set-aside requirements. Amerisourcebergen Drug...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceuticals, with an ultimate completion date of December 11, 2024. The $100,402.15 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order and is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS to the Defense Logistics Agency (DLA). The $2,866.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of December 4, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical. The IDC...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency, by the prime contractor Amerisourcebergen Drug Corp. The $29,323.35 contract is a firm fixed-price delivery order with a completion date of May 27, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, holds a significant $999,999,999.00 Indefinite Delivery...
This federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,388.75 and an ultimate completion date of December 18, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.37 firm fixed-price delivery order contract is for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. The contract has an ultimate completion date of May 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
  • SPE2DB24D3015
    Indefinite Delivery Contract
  • SPE2DB24D3015-SPE2DB24FFXQY
    Delivery Order

The federal contract award is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,454.37 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with an ultimate completion date of September 6, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/5/24, 9:46 AM